Sevindik, Ömür GökmenÖzkurt, Zübeyde NurBoğa, CanKalayoğlu Beşışık, Sevgiİpek, YıldızGedük, AyferHarmandalı, AybükeSalihoğlu, AyşeHaydaroğlu Şahin, HandanSönmez, MehmetVural, FilizAkay, Olga MeltemKurt Yüksel, MeltemMaral, SenemEkinci, ÖmerKırkızlar, Hakkı OnurTekinalp, AtakanDemir, NazlıMerter, MustafaSaydam, GürayAlacacıoğlu, İnciYeğin, Zeynep ArzuKasar, MutluMastanzade, MetbanÖzsan, Güner Hayri2021-12-062021-12-062021Sevindik, Ö. G., Özkurt, Z. N., Boğa, C., Kalayoğlu Beşışık, S., İpek, Y., Gedük, A. ... Özsan, G. H. (2021). An interim analysis of the Turkish Myeloma Registry among patients who have received up to two lines of therapy. Clinical Lymphoma, Myeloma & Leukemia içinde (S102-S103. ss.).2152-26502152-2669https://hdl.handle.net/20.500.12511/8618Background To investigate the demographics and treatment details of the myeloma patients who were diagnosed and followed up in Turkey and received up to two lines of therapy. Methods Patients who were recorded on the database of Turkish Myeloma Registry project were included in this study if they had only received one or two lines of therapy. Demographics, patient, and disease related parameters both at the time of diagnosis and at the follow up and treatment outcomes were presented.eninfo:eu-repo/semantics/embargoedAccessTurkish Myeloma RegistryLines of TherapyInterim AnalysisConference Object21Supplement:2S102S103Q3